Skeletal muscle nitric oxide (NO) synthases and NO-signaling in “diabesity” – What about the relevance of exercise training interventions?

Nitric Oxide - Tập 37 - Trang 28-40 - 2014
Kaveh Eghbalzadeh1, Klara Brixius1, Wilhelm Bloch1, Christian Brinkmann1
1Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University, Cologne, Germany

Tài liệu tham khảo

Shaw, 2010, Global estimates of the prevalence of diabetes for 2010 and 2030, Diabetes Res. Clin. Pract., 87, 4, 10.1016/j.diabres.2009.10.007 Clark, 2002, The microvasculature in insulin resistance and type 2 diabetes, Semin. Vasc. Med., 2, 21, 10.1055/s-2002-23506 DeFronzo, 2010, Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard lecture 2009, Diabetologia, 53, 1270, 10.1007/s00125-010-1684-1 McConell, 2008, Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle, Clin. Exp. Pharmacol. Physiol., 35, 1488 Kaneki, 2007, Nitrosative stress and pathogenesis of insulin resistance, Antioxid. Redox Signal., 9, 319, 10.1089/ars.2006.1464 Le Gouill, 2007, Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation, Diabetes, 56, 2690, 10.2337/db06-1228 Shankar, 2000, Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance, Diabetes, 49, 684, 10.2337/diabetes.49.5.684 Chavoshan, 2012, Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men, Respir. Med., 106, 269, 10.1016/j.rmed.2011.07.018 Frandsen, 1996, Localization of nitric oxide synthase in human skeletal muscle, Biochem. Biophys. Res. Commun., 227, 88, 10.1006/bbrc.1996.1472 McConell, 2007, Skeletal muscle nNOS mu protein content is increased by exercise training in humans, Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R821, 10.1152/ajpregu.00796.2006 Punkt, 2006, Nitric oxide synthase in human skeletal muscles related to defined fibre types, Histochem. Cell Biol., 125, 567, 10.1007/s00418-005-0108-7 Venema, 1997, Subunit interactions of endothelial nitric-oxide synthase. Comparisons to the neuronal and inducible nitric-oxide synthase isoforms, J. Biol. Chem., 272, 1276, 10.1074/jbc.272.2.1276 Wakayama, 1997, Ultrastructural localization of alpha 1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relation to each other and to dystrophin, Acta Neuropathol., 94, 455, 10.1007/s004010050733 Gath, 1999, NO synthase II in mouse skeletal muscle is associated with caveolin 3, Biochem. J., 340, 723, 10.1042/0264-6021:3400723 Stamler, 2001, Physiology of nitric oxide in skeletal muscle, Physiol. Rev., 81, 209, 10.1152/physrev.2001.81.1.209 Punkt, 2013, Nitric oxide synthase in skeletal muscle fibers of patients with type 2 diabetes, Acta Histochem., 115, 389, 10.1016/j.acthis.2012.09.014 Santolini, 2001, Differences in three kinetic parameters underpin the unique catalytic profiles of nitric-oxide synthases I, II, and III, J. Biol. Chem., 276, 48887, 10.1074/jbc.M108666200 Soskić, 2011, Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure, Open Cardiovasc. Med. J., 5, 153, 10.2174/1874192401105010153 Aktan, 2004, INOS-mediated nitric oxide production and its regulation, Life Sci., 75, 639, 10.1016/j.lfs.2003.10.042 Rafikov, 2011, ENOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity, J. Endocrinol., 210, 271, 10.1530/JOE-11-0083 Lau, 2000, NNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle, Physiol. Genomics, 2, 21, 10.1152/physiolgenomics.2000.2.1.21 Silvagno, 1996, Neuronal nitric-oxide synthase-mu, an alternatively spliced isoform expressed in differentiated skeletal muscle, J. Biol. Chem., 271, 11204, 10.1074/jbc.271.19.11204 Baum, 2011, The beta-isoform of neuronal nitric oxide synthase (nNOS) lacking the PDZ domain is localized at the sarcolemma, FEBS Lett., 585, 3219, 10.1016/j.febslet.2011.09.016 Bradley, 2007, Skeletal muscle neuronal nitric oxide synthase micro protein is reduced in people with impaired glucose homeostasis and is not normalized by exercise training, Metab. Clin. Exp., 56, 1405, 10.1016/j.metabol.2007.06.003 Krause, 2012, Differential nitric oxide levels in the blood and skeletal muscle of type 2 diabetic subjects may be consequence of adiposity: a preliminary study, Metab. Clin. Exp., 61, 1528, 10.1016/j.metabol.2012.05.003 Torres, 2004, Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients, J. Endocrinol., 181, 419, 10.1677/joe.0.1810419 Perreault, 2001, Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle, Nat. Med., 7, 1138, 10.1038/nm1001-1138 Sugita, 2005, Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells, J. Biol. Chem., 280, 14203, 10.1074/jbc.M411226200 Mourmoura, 2013, Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo, Cardiovasc. Diabetol., 12, 49, 10.1186/1475-2840-12-49 Huang, 2012, Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress, Am. J. Physiol. Regul. Integr. Comp. Physiol., 302, R674, 10.1152/ajpregu.00699.2011 Shimabukuro, 1997, Role of nitric oxide in obesity-induced beta cell disease, J. Clin. Invest., 100, 290, 10.1172/JCI119534 Erdely, 2004, Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production, Diabetologia, 47, 1672, 10.1007/s00125-004-1509-1 Prabhakar, 2007, Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production, J. Am. Soc. Nephrol., 18, 2945, 10.1681/ASN.2006080895 Bachetti, 2004, Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells, J. Mol. Cell. Cardiol., 37, 939, 10.1016/j.yjmcc.2004.07.006 Eringa, 2013, Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes, Rev. Endocr. Metab. Disord., 14, 39, 10.1007/s11154-013-9239-7 Ginnan, 2008, Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases, Free Radic. Biol. Med., 44, 1232, 10.1016/j.freeradbiomed.2007.12.025 Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137 LaPointe, 1999, Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes, Hypertension, 33, 276, 10.1161/01.HYP.33.1.276 Pawate, 2006, C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform, Antioxid. Redox Signal., 8, 903, 10.1089/ars.2006.8.903 Xu, 2008, Activation of cytosolic phospholipase A2alpha through nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2, J. Biol. Chem., 283, 3077, 10.1074/jbc.M705709200 Xia, 2001, NF-kappaB activation for constitutive expression of VCAM-1 and ICAM-1 on B lymphocytes and plasma cells, Biochem. Biophys. Res. Commun., 289, 851, 10.1006/bbrc.2001.6067 Jiang, 2002, Growth factors enhance interleukin-1 beta-induced persistent activation of nuclear factor-kappa B in rat vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 22, 1811, 10.1161/01.ATV.0000037679.60584.3F Kang, 2012, N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression, J. Cell. Biochem., 113, 2845, 10.1002/jcb.24159 Béraud, 1999, Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation, Proc. Natl. Acad. Sci. USA, 96, 429, 10.1073/pnas.96.2.429 Jiang, 2004, Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression, J. Biol. Chem., 279, 1323, 10.1074/jbc.M307521200 Kim, 2007, J. Pharmacol. Exp. Ther., 320, 782, 10.1124/jpet.106.112052 Kwon, 1999, J. Biol. Chem., 274, 18702, 10.1074/jbc.274.26.18702 Li, 1998, Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha, FASEB J., 12, 871, 10.1096/fasebj.12.10.871 O’Neill, 1998, Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants, J. Leukoc. Biol., 63, 650, 10.1002/jlb.63.6.650 Teixeira de Lemos, 2011, Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties, Cardiovasc. Diabetol., 10, 12, 10.1186/1475-2840-10-12 Barbarroja, 2012, Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation, PLoS One, 7, e48155, 10.1371/journal.pone.0048155 Creely, 2007, Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes, Am. J. Physiol. Endocrinol. Metab., 292, E740, 10.1152/ajpendo.00302.2006 Pandey, 2010, Protein oxidation biomarkers in plasma of type 2 diabetic patients, Clin. Biochem., 43, 508, 10.1016/j.clinbiochem.2009.11.011 Syrenicz, 2006, Low-grade systemic inflammation and the risk of type 2 diabetes in obese children and adolescents, Neuro Endocrinol. Lett., 27, 453 Dell’Albani, 2001, Giuffrida Stella, A M, JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures, J. Neurosci. Res., 65, 417, 10.1002/jnr.1169 Ji, 2011, β-Escin sodium inhibits inducible nitric oxide synthase expression via downregulation of the JAK/STAT pathway in A549 cells, Mol. Carcinog., 50, 945, 10.1002/mc.20762 Rauch, 2013, The regulation of inflammation by interferons and their STATs, JAKSTAT, 2, e23820 Nosratabadi, 2009, Evaluation of IFN-gamma serum level in nephropatic type 2 diabetic patients, Pak. J. Biol. Sci., 12, 746, 10.3923/pjbs.2009.746.749 Surendar, 2011, Increased levels of both Th1 and Th2 cytokines in subjects with metabolic syndrome (CURES-103), Diabetes Technol. Ther., 13, 477, 10.1089/dia.2010.0178 Rao, 2000, Molecular mechanisms regulating iNOS expression in various cell types, J. Toxicol. Environ. Health B Crit. Rev., 3, 27, 10.1080/109374000281131 Okugawa, 2003, Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages, Am. J. Physiol. Cell Physiol., 285, C399, 10.1152/ajpcell.00026.2003 Adams, 2002, Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study, Cardiovasc. Res., 54, 95, 10.1016/S0008-6363(02)00228-6 Adams, 2003, Nuclear factor-kappa B activation in skeletal muscle of patients with chronic heart failure: correlation with the expression of inducible nitric oxide synthase, Eur. J. Cardiovasc. Prev. Rehabil., 10, 273, 10.1097/00149831-200308000-00009 Agustí, 2004, NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight, Thorax, 59, 483, 10.1136/thx.2003.017640 Frost, 2004, Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C(2)C(12) myoblasts via Toll-like receptor-4 and c-Jun NH(2)-terminal kinase pathways, Am. J. Physiol., Cell Physiol., 287, C1605, 10.1152/ajpcell.00010.2004 Carvalho-Filho, 2005, S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance, Diabetes, 54, 959, 10.2337/diabetes.54.4.959 Lira, 2007, Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle, Am. J. Physiol. Endocrinol. Metab., 293, E1062, 10.1152/ajpendo.00045.2007 Bédard, 1997, Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase, Biochem. J., 325, 487, 10.1042/bj3250487 Anand, 2012, Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease, J. Mol. Med., 90, 233, 10.1007/s00109-012-0878-z Carvalho-Filho, 2006, Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice, Am. J. Physiol. Endocrinol. Metab., 291, E476, 10.1152/ajpendo.00422.2005 Yasukawa, 2005, Martyn, J A Jeevendra, M. Kaneki, S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance, J. Biol. Chem., 280, 7511, 10.1074/jbc.M411871200 Butzer, 1999, Increased oxidative stress in the RAW 264.7 macrophage cell line is partially mediated via the S-nitrosothiol-induced inhibition of glutathione reductase, FEBS Lett., 445, 274, 10.1016/S0014-5793(99)00139-8 Radi, 2013, Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects, Acc. Chem. Res., 46, 550, 10.1021/ar300234c Pacher, 2007, Nitric oxide and peroxynitrite in health and disease, Physiol. Rev., 87, 315, 10.1152/physrev.00029.2006 Gow, 1996, Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration, Arch. Biochem. Biophys., 333, 42, 10.1006/abbi.1996.0362 Pilon, 2010, Endotoxin mediated-iNOS induction causes insulin resistance via ONOO− induced tyrosine nitration of IRS-1 in skeletal muscle, PLoS One, 5, e15912, 10.1371/journal.pone.0015912 Zhou, 2009, Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRβ/IRS-1 and Akt, Toxicol. App. Pharmacol., 241, 101, 10.1016/j.taap.2009.08.005 Laakso, 1990, Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance, J. Clin. Invest., 85, 1844, 10.1172/JCI114644 Vincent, 2003, Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin, Am. J. Physiol. Endocrinol. Metab., 285, E123, 10.1152/ajpendo.00021.2003 Bradley, 2013, Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo, Am. J. Physiol. Endocrinol. Metab., 305, E745, 10.1152/ajpendo.00289.2013 Scherrer, 1997, Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity, Circulation, 96, 4104, 10.1161/01.CIR.96.11.4104 Uno, 2006, Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity, Science, 312, 1656, 10.1126/science.1126010 Roberts, 1999, Acute exercise increases nitric oxide synthase activity in skeletal muscle, Am. J. Physiol., 277, E390 Young, 1997, Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro, Biochem. J., 322, 223, 10.1042/bj3220223 Roberts, 1997, Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent, Am. J. Physiol., 273, E220 Merry, 2009, Skeletal muscle glucose uptake during exercise: a focus on reactive oxygen species and nitric oxide signaling, IUBMB Life, 61, 479, 10.1002/iub.179 Kingwell, 2002, Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects, Diabetes, 51, 2572, 10.2337/diabetes.51.8.2572 Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes, 51, 2944, 10.2337/diabetes.51.10.2944 Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes, 56, 1592, 10.2337/db06-0981 Morino, 2006, Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction, Diabetes, 55, S9, 10.2337/db06-S002 Ritov, 2005, Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes, Diabetes, 54, 8, 10.2337/diabetes.54.1.8 Moncada, 2002, Does nitric oxide modulate mitochondrial energy generation and apoptosis?, Nat. Rev. Mol. Cell Biol., 3, 214, 10.1038/nrm762 Tengan, 2007, The role of nitric oxide in muscle fibers with oxidative phosphorylation defects, Biochem. Biophys. Res. Commun., 359, 771, 10.1016/j.bbrc.2007.05.184 Nisoli, 2003, Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide, Science, 299, 896, 10.1126/science.1079368 Nisoli, 2004, Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals, Proc. Natl. Acad. Sci. USA, 101, 16507, 10.1073/pnas.0405432101 Stamler, 1992, S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds, Proc. Natl. Acad. Sci. USA, 89, 444, 10.1073/pnas.89.1.444 Lira, 2010, Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells, J. Physiol. (Lond.), 588, 3551, 10.1113/jphysiol.2010.194035 Wadley, 2007, Effect of nitric oxide synthase inhibition on mitochondrial biogenesis in rat skeletal muscle, J. Appl. Physiol., 102, 314, 10.1152/japplphysiol.00549.2006 Wadley, 2007, NOS isoform-specific regulation of basal but not exercise-induced mitochondrial biogenesis in mouse skeletal muscle, J. Physiol. (Lond.), 585, 253, 10.1113/jphysiol.2007.141309 de Filippis, 2008, Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise, Am. J. Physiol. Endocrinol. Metab., 294, E607, 10.1152/ajpendo.00729.2007 Chung, 2012, Training-induced alterations of skeletal muscle mitochondrial biogenesis proteins in non-insulin-dependent type 2 diabetic men, Can. J. Physiol. Pharmacol., 90, 1634, 10.1139/y2012-144 Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet., 34, 267, 10.1038/ng1180 Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1, Proc. Natl. Acad. Sci. USA, 100, 8466, 10.1073/pnas.1032913100 Tengan, 2012, Nitric oxide in skeletal muscle: role on mitochondrial biogenesis and function, IJMS, 13, 17160, 10.3390/ijms131217160 Brown, 1994, Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase, FEBS Lett., 356, 295, 10.1016/0014-5793(94)01290-3 Palacios-Callender, 2007, Cytochrome c oxidase maintains mitochondrial respiration during partial inhibition by nitric oxide, J. Cell. Sci., 120, 160, 10.1242/jcs.03308 Suhr, 2013, Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxide, Int. J. Mol. Sci., 14, 7109, 10.3390/ijms14047109 Heinonen, 2011, Skeletal muscle blood flow and oxygen uptake at rest and during exercise in humans: a pet study with nitric oxide and cyclooxygenase inhibition, Am. J. Physiol. Heart Circ. Physiol., 300, H1510, 10.1152/ajpheart.00996.2010 Rådegran, 1999, Nitric oxide in the regulation of vasomotor tone in human skeletal muscle, Am. J. Physiol., 276, H1951 Guo, 2001, Nitric oxide inhibits expression of cytochrome B in endotoxin-stimulated murine macrophages, Biochem. Biophys. Res. Commun., 289, 993, 10.1006/bbrc.2001.6107 Poderoso, 1996, Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles, Arch. Biochem. Biophys., 328, 85, 10.1006/abbi.1996.0146 Brown, 2002, Nitric oxide inhibition of mitochondrial respiration and its role in cell death, Free Radic. Biol. Med., 33, 1440, 10.1016/S0891-5849(02)01112-7 Borutaite, 2006, S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production, Biochim. Biophys. Acta, 1757, 562, 10.1016/j.bbabio.2006.02.014 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Anderson, 2009, Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans, J. Clin. Invest., 119, 573, 10.1172/JCI37048 Radi, 2002, Peroxynitrite reactions and formation in mitochondria, Free Radic. Biol. Med., 33, 1451, 10.1016/S0891-5849(02)01111-5 Boushel, 2007, Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle, Diabetologia, 50, 790, 10.1007/s00125-007-0594-3 Conley, 2007, Mitochondrial dysfunction: impact on exercise performance and cellular aging, Exerc. Sport Sci. Rev., 35, 43, 10.1249/JES.0b013e31803e88e9 Martins, 2012, Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function, Lipids Health Dis., 11, 30, 10.1186/1476-511X-11-30 Schmitz-Peiffer, 1997, Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat, Diabetes, 46, 169, 10.2337/diab.46.2.169 Wallace, 2005, A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine, Annu. Rev. Genet., 39, 359, 10.1146/annurev.genet.39.110304.095751 Bloch-Damti, 2006, Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress, Diabetologia, 49, 2463, 10.1007/s00125-006-0349-6 Dey, 2005, Inhibition of insulin receptor gene expression and insulin signaling by fatty acid: interplay of PKC isoforms therein, Cell. Physiol. Biochem., 16, 217, 10.1159/000089847 Jové, 2005, Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta from its inhibition by palmitate-induced nuclear factor-kappaB in skeletal muscle cells, Biochim. Biophys. Acta, 1734, 52, 10.1016/j.bbalip.2005.02.002 Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005 Lanza, 2009, Muscle mitochondrial changes with aging and exercise, Am. J. Clin. Nutr., 89, 467S, 10.3945/ajcn.2008.26717D Stump, 2003, Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts, Proc. Natl. Acad. Sci. USA, 100, 7996, 10.1073/pnas.1332551100 Gielen, 2003, Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure, J. Am. Coll. Cardiol., 42, 861, 10.1016/S0735-1097(03)00848-9 Hansen, 2011, Exercise training alters the balance between vasoactive compounds in skeletal muscle of individuals with essential hypertension, Hypertension, 58, 943, 10.1161/HYPERTENSIONAHA.111.176529 Høier, 2010, The effect of passive movement training on angiogenic factors and capillary growth in human skeletal muscle, J. Physiol. (Lond.), 588, 3833, 10.1113/jphysiol.2010.190439 Hoier, 2012, Pro- and anti-angiogenic factors in human skeletal muscle in response to acute exercise and training, J. Physiol., 590, 595, 10.1113/jphysiol.2011.216135 Balon, 1997, Evidence that nitric oxide increases glucose transport in skeletal muscle, J. Appl. Physiol., 82, 359, 10.1152/jappl.1997.82.1.359 Ren, 2010, Chronic hypoxia and exercise training affect the NO content and NOS activity of rat skeletal muscle, Int. J. Sports Med., 11, 244 Song, 2009, Exercise training modulates the nitric oxide synthase profile in skeletal muscle from old rats, J. Gerontol. A Biol. Sci. Med. Sci., 540, 10.1093/gerona/glp021 Tatchum-Talom, 2000, Upregulation of neuronal nitric oxide synthase in skeletal muscle by swim training, Am. J. Physiol. Heart Circ. Physiol., 279, H1757, 10.1152/ajpheart.2000.279.4.H1757 Vassilakopoulos, 2003, Regulation of nitric oxide production in limb and ventilatory muscles during chronic exercise training, Am. J. Physiol. Lung Cell Mol. Physiol., 284, L452, 10.1152/ajplung.00270.2002 Chen, 2000, AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation, Am. J. Physiol. Endocrinol. Metab., 279, E1202, 10.1152/ajpendo.2000.279.5.E1202 King-Vanvlack, 1995, Role of endothelial factors in active hyperemic responses in contracting canine muscle, J. Appl. Physiol., 79, 107, 10.1152/jappl.1995.79.1.107 Reid, 2001, Nitric oxide, reactive oxygen species, and skeletal muscle contraction, Med Sci Sports Exerc, 33, 371, 10.1097/00005768-200103000-00006 McConell, 2012, Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism, Am. J. Physiol. Endocrinol. Metab., 303, E301, 10.1152/ajpendo.00667.2011 Abd El-Kader, 2011, Aerobic versus resistance exercise training in modulation of insulin resistance, adipocytokines and inflammatory cytokine levels in obese type 2 diabetic patients, J. Adv. Res., 2, 179, 10.1016/j.jare.2010.09.003 Balducci, 2010, Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss, Nutr. Metab. Cardiovasc. Dis., 20, 608, 10.1016/j.numecd.2009.04.015 Giannopoulou, 2005, Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes, Metab. Clin. Exp., 54, 866, 10.1016/j.metabol.2005.01.033 Iborra, 2008, Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus, Scand. J. Med. Sci. Sports, 18, 742, 10.1111/j.1600-0838.2007.00748.x Kadoglou Nikolaos, 2007, The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus, Eur. J. Cardiovasc. Prev. Rehabil., 14, 837, 10.1097/HJR.0b013e3282efaf50 Kurban, 2011, Effect of chronic regular exercise on serum ischemia-modified albumin levels and oxidative stress in type 2 diabetes mellitus, Endocr. Res., 36, 116, 10.3109/07435800.2011.566236 Lazarevic, 2008, Effects of regular exercise on cardiovascular risk factors profile and oxidative stress in obese type 2 diabetic patients in regard to score risk, Acta Cardiol., 63, 485, 10.2143/AC.63.4.2033048 Roberts, 2006, Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men, Diabetes Res. Clin. Pract., 73, 249, 10.1016/j.diabres.2006.02.013 Straczkowski, 2001, Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance, Eur. J. Endocrinol., 145, 273, 10.1530/eje.0.1450273 Wycherley, 2008, Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes, Diabetes Obes. Metab., 10, 1062, 10.1111/j.1463-1326.2008.00863.x Teixeira de Lemos, 2007, Exercise training is associated with improved levels of C reactive protein and adiponectin in ZDF (type 2) diabetic rats, Med. Sci. Monit., 13, BR168 Teixeira de Lemos, 2009, Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats, Nutrition, 25, 330, 10.1016/j.nut.2008.08.014 Hey-Mogensen, 2010, Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes, Diabetologia, 53, 1976, 10.1007/s00125-010-1813-x Meex Ruth, 2010, The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without type 2 diabetes, Clin. Sci., 119, 293, 10.1042/CS20100153 Phielix, 2010, Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals, Diabetologia, 53, 1714, 10.1007/s00125-010-1764-2 Toledo, 2007, Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes, Diabetes, 56, 2142, 10.2337/db07-0141 Golbidi, 2012, Antioxidant and anti-inflammatory effects of exercise in diabetic patients, Exp. Diabetes Res., 2012, 941868, 10.1155/2012/941868 Wang, 2009, Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes or impaired glucose tolerance: a systematic review, Diabetes Metab. Res. Rev, 25, 13, 10.1002/dmrr.928